0.3900
+0.0100
+(2.63%)
At close: January 10 at 1:29:31 PM EST
Breakdown
TTM
8/31/2024
8/31/2023
8/31/2022
8/31/2021
Operating Cash Flow
19.8010
19.8010
-1,756.9730
-1,371.1650
-940.9970
Investing Cash Flow
-39.6020
-39.6020
-35.7650
-1,203.7300
-599.5660
Financing Cash Flow
--
--
1,430.0540
--
4,785.8800
End Cash Position
337.0080
337.0080
356.8090
719.4930
3,294.3880
Capital Expenditure
-39.6020
-39.6020
-35.7650
-1,203.7300
-599.5660
Issuance of Capital Stock
--
--
1,430.0540
--
4,792.6970
Repayment of Debt
--
--
--
--
-7.0700
Free Cash Flow
-19.8010
-19.8010
-1,792.7380
-2,574.8950
-1,540.5630
8/31/2021 - 10/19/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
IMC.AX Immuron Limited
0.0820
0.00%
MEM.AX Memphasys Limited
0.0090
-10.00%
GSD.V Devonian Health Group Inc.
0.1650
0.00%
EZZ.AX EZZ Life Science Holdings Limited
2.6800
+2.29%
GLOW.CN Glow Lifetech Corp.
0.0600
0.00%
IMRN Immuron Limited
1.9500
-3.94%
CVALF Covalon Technologies Ltd.
2.2100
-3.49%
NRX.V NurExone Biologic Inc.
0.6800
+4.62%
MBX.TO Microbix Biosystems Inc.
0.4200
+1.20%
CSBR Champions Oncology, Inc.
9.47
-1.97%